Relapse in multiple sclerosis
Relapse in multiple sclerosis
Relapse of multiple sclerosis is a patient reported, or objectively observed, event typical of an acute inflammatory demyelinating event in the central nervous system, current or historical, with a duration of at least 24 hours.
The differential diagnosis of a relapse includes alternative neurological diagnoses, pseudo-relapses, short lived paroxysmal symptoms, day to day fluctuations, and functional symptoms.
Clinically significant or severe relapses may benefit from treatment with corticosteroid for five days.
Documentation and timely communication of the relapse to the patient’s multiple sclerosis specialist service, such as through the multiple sclerosis specialist nurse, is important, to enable timely decisions on immunotherapy initiation or escalation.
Non-adherence with immunotherapy is under-recognised by both patients and doctors.
h1765
Galea, Ian
66209a2f-f7e6-4d63-afe4-e9299f156f0b
Ward-Abel, Nicki
03d0b4e8-bdb3-4192-9a92-1872094808d9
Heesen, Christoph
1f483c47-8edd-4655-aec3-db243d891310
2015
Galea, Ian
66209a2f-f7e6-4d63-afe4-e9299f156f0b
Ward-Abel, Nicki
03d0b4e8-bdb3-4192-9a92-1872094808d9
Heesen, Christoph
1f483c47-8edd-4655-aec3-db243d891310
Abstract
Relapse of multiple sclerosis is a patient reported, or objectively observed, event typical of an acute inflammatory demyelinating event in the central nervous system, current or historical, with a duration of at least 24 hours.
The differential diagnosis of a relapse includes alternative neurological diagnoses, pseudo-relapses, short lived paroxysmal symptoms, day to day fluctuations, and functional symptoms.
Clinically significant or severe relapses may benefit from treatment with corticosteroid for five days.
Documentation and timely communication of the relapse to the patient’s multiple sclerosis specialist service, such as through the multiple sclerosis specialist nurse, is important, to enable timely decisions on immunotherapy initiation or escalation.
Non-adherence with immunotherapy is under-recognised by both patients and doctors.
Text
__soton.ac.uk_ude_personalfiles_users_ig1_mydocuments_Clinical Neurosciences_BMJ review_Galea et al 2015.pdf
- Version of Record
More information
Published date: 2015
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 384270
URI: http://eprints.soton.ac.uk/id/eprint/384270
ISSN: 0959-8138
PURE UUID: 7b3e70ac-f27c-4209-ba59-213c6558a08d
Catalogue record
Date deposited: 30 Nov 2015 09:36
Last modified: 15 Mar 2024 03:16
Export record
Altmetrics
Contributors
Author:
Nicki Ward-Abel
Author:
Christoph Heesen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
